GLG News by Psychiatrists

This article tells you only that the drugs are equally effective, but not what that really means in real life.

Astra Zeneca is pursuing important medical and, of course, commercial goals by seeking the expanded clinical indications of major depression and generalized anxiety disorder for Seroquel XR, heir to blockbuster Seroquel (quetiapine).  This latest EU submission culminates regulatory submissions...

Seroquel is an atypical antipsychotic that has efficacy in 2 very serious mental illnesses- schizophrenia and bipolar disorder. A symptom of both illnesses can be cognitive impairment , confusion, and non-compliance. A once a day formulation of any of their meds helps with compliance and thus maximizes...

This "report" tells you nothing that you need to know in order to assess the validity of these studies.  We have always known that St. John's Wort has some effectiveness---but it certainly does not come without side-effects.  Where is the information about the length of the studies, the relative...

Gamma secretase inhibitors are one of several kinds of drugs being studied for the prevention/amelioration of Alzheimer's.  In concept they make sense.

This brief news is warning againts any procedural delay to market prices of generic versions of brand-name drugs. The eventual outcome is unexpected overpayment for generic brand. Is this a problem arising from computer pricing or a stratetgic decision making issue on how to label generic drugs...

This is hardly news to any practicing psychiatrist. It has become a profession devoid of any meaning. The quality of treatment has deteriorated beyond belief. 

Unfortunately, many insurance payors do not realize that allowing psychotherapy visits may save the money in the long run by reducing the need for much more costly Inpatient psychiatric treatment. I find that my patients who receive psychotherapy are much less likely to miss work and much...

This large study shows that PD patients' severity of motor dysfunction is better on rasagiline than on placebo.

More psychiatrists are doing less exclusively psychotherapy in their practices than in past years. The implication is that there is a relatively higher percentage of psychiatrists who will need to know about the latest development of psychopharmacology . Whereas in the past psychiatrists who were psychoanalysts...